PROVIBOLIC - Mesterolone 20mg/25mg

Category:- Hormones | Type:- Tablet

COMPOSITION

Each tablet contains: Mesterolone 25 mg

PHARMACOLOGICALCLASSIFICATION

Male sex hormones.

PHARMACOLOGICALACTION

Mesterolone balances a deficiency of androgen formation which begins to fall gradually with increasing age. Therefore, Mesterolone is suitable for treatment of all conditions caused by deficient endogenous androgen formation. In the recommended therapeutic dosage, Mesterolone will not impair spermatogenesis. Mesterolone is especially well tolerated by the liver.

INDICATIONS

Declining physical activity and mental alertness in middle- and old-aged men Reduced efficiency, easy fatigability, lack of concentration, weak memory, disturbances of libido and potency, irritability, disturbances of sleep, depressive moods, and general vegetative complaints are often attributed to androgen-deficiency. These complaints can be overcome or improved by the use of Mesterolone tablets.

• Potency disturbances Mesterolone overcomes potency disturbances due to androgen-deficiency. It may also be of use as supplementary therapy in cases of diminished potency where androgen-deficiency is not the primary cause.

• Hypogonadism Growth, development and function of androgen-dependent target organs are stimulated by Mesterolone. It promotes development of secondary male sex characteristics in cases of prepuberal hypogonadism. Full clinical and laboratory investigations are necessary in all cases of young patients prior to commencement of treatment. Mesterolone tablets may also be used as a substitution therapy in cases where a loss of gonadal function has occurred post-puberally.

• Infertility Oligozoospermia and deficient Leydig-cell secretion may be the cause of infertility. With Mesterolone treatment, sperm count can be increased, the quality improved and, furthermore, a higher fructose concentration up to normal values can be achieved thus increasing the chances of procreation.

CONTRA-INDICATIONS

In patients with carcinoma of the prostate, androgen therapy of any kind, including the use of Mesterolone, is contraindicated.

DOSAGE AND DIRECTIONS FOR USE

If not otherwise directed by the physician, the following dosage is recommended: In declining physical activity and potency disturbances Commencement of treatment: Mesterolone tablet of 25 mg three times daily. Continuation of treatment: Mesterolone tablet of 25 mg twice or once daily. According to type and severity of the complaints, a course of Mesterolone lasting four to six weeks or a prolonged uninterrupted treatment over several months is recommended. If required, the course of treatment may be repeated several times. Hypogonadism requires continuous therapy For development of secondary male sex characteristics 1 Mesterolone tablet of 25 mg 3-4 times daily for several months. As maintenance dose 1 Mesterolone tablet of 25 mg twice or three times daily will be sufficient. In oligozoospermia Mesterolone tablet of 25 mg twice or three times daily for a cycle of spermatogenesis, ie 90 days. In case of simultaneously impaired gonadotrophic excretion, a combined therapy with gonadotrophic hormone exhibiting FSH activity is recommended for the commencement of treatment (eg 2000 IU serum gonadotrophin im twice weekly up to a total amount of 12 000 IU). If necessary, Mesterolone treatment is to be repeated after an interval of several weeks.

SIDE EFFECTS AND SPECIALPRECAUTIONS

The administration of Mesterolone is recommended only for male patients. Regular examinations of the prostate should be carried out prophylactically

KNOWN SYMPTOMS OFOVERDOSAGE AND PARTICULARS OFITS TREATMENT

None.

PRESENTATION 5 x 10 tablets in a blister packed in carton along with package insert. STORAGE INSTRUCTION Store below 30°C in a dry place. Protect from light.

KEEP OUT OF REACH OF CHILDREN

Manufactured by: COOPER PHARMA LIMITED